SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001125345-22-000070
Filing Date
2022-05-24
Accepted
2022-05-24 08:38:20
Documents
14
Period of Report
2022-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20220522.htm   iXBRL 8-K 37976
2 EX-99.1 exhibit99-1heidenappt52322.htm EX-99.1 11792
6 image_0.jpg GRAPHIC 16939
  Complete submission text file 0001125345-22-000070.txt   215309

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20220522.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20220522_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20220522_pre.xml EX-101.PRE 12506
8 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20220522_htm.xml XML 11264
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 22954086
SIC: 2834 Pharmaceutical Preparations